(Q42285880)

19 October 2017

The safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B. (English)

1 reference

19 October 2017

1 reference

Dimitrios P Kontoyiannis

series ordinal

3

object named as

Dimitrios P Kontoyiannis

1 reference

19 October 2017

Dimitrios Farmakiotis

series ordinal

1

1 reference

PubMed ID

23166189

19 October 2017

Frank P Tverdek

series ordinal

2

1 reference

PubMed ID

23166189

19 October 2017

language of work or name

English

0 references

publication date

19 November 2012

1 reference

Clinical Infectious Diseases

19 October 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 October 2017

56

1 reference

19 October 2017

5

1 reference

19 October 2017

701-703

1 reference

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence

19 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS972

Lipid formulations of amphotericin B: clinical efficacy and toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS972

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS972

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS972

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS972

Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS972

Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS972

21 January 2018

Identifiers

DOI

10.1093/CID/CIS972

1 reference

19 October 2017

1 reference

PubMed ID

23166189